CD274 and melanoma: Support for targeting PD-L1 by ICI therapy in melanoma can be seen from an analysis of the TCGA-Melanoma datasets (TCGA-SKCM), where high expression of PD-L1 (CD274) is associated with better OS (Supplementary Fig. S7).